Can Osteopontin Be Considered a Biomarker for Endometriosis?

التفاصيل البيبلوغرافية
العنوان: Can Osteopontin Be Considered a Biomarker for Endometriosis?
المؤلفون: Irina Dumitrascu, Gabriel Costachescu, Carmen Vulpoi, Daniela Constantinescu, Elena Mihalceanu, Daniela Roxana Albu, Alina Pangal, Luciana Carmen Nitoi, Mircea Onofriescu, Alexandra Mihaila
المصدر: Scopus-Elsevier
بيانات النشر: Revista de Chimie SRL, 2017.
سنة النشر: 2017
مصطلحات موضوعية: biology, business.industry, Materials Science (miscellaneous), Process Chemistry and Technology, General Engineering, Endometriosis, General Chemistry, General Medicine, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Materials Chemistry, medicine, Cancer research, biology.protein, Biomarker (medicine), Osteopontin, General Pharmacology, Toxicology and Pharmaceutics, business
الوصف: Endometriosis is a multifactorial disease that is manifested by infertility and pelvic pain. The purpose of the study was to evaluate the effect of progesterone treatment on the serum level of osteopontin, a multipotent cytokine, in patients with endometriosis. The study was prospective and we evaluated osteopontin levels that were measured in the serum of 40 patients with endometriosis and 12 healthy women using a standardized Enzyme-Linked Immunosorbent Assay (ELISA) kit. Osteopontin seric levels were lower in endometriosis patients and increased after progesterone treatment. Because of the large dispersion of data even in the control group, we find the association between osteopontin and endometriosis questionable.
تدمد: 2668-8212
0034-7752
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e1079476a14f9935a748c9d421dea43Test
https://doi.org/10.37358/rc.17.9.5840Test
رقم الانضمام: edsair.doi.dedup.....7e1079476a14f9935a748c9d421dea43
قاعدة البيانات: OpenAIRE